×
Healthcare stocks are climbing as DeepSeek AI market sell-off continues
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

The release of DeepSeek, a Chinese AI startup’s technology, has triggered significant market movements, particularly affecting artificial intelligence and healthcare stocks.

Market impact overview: The S&P 500 experienced a decline driven by AI-related stocks, while healthcare stocks showed strength.

  • Nvidia and Broadcom shares dropped more than 15% as investors questioned the future demand for their chips
  • Healthcare stocks, including Eli Lilly, Bristol Myers Squibb, and Danaher, continued their upward momentum
  • Consumer staples and interest rate-sensitive stocks like Home Depot showed resilience amid the AI uncertainty

DeepSeek implications: The Chinese startup’s claimed efficient AI model development has sparked debates about the future of AI infrastructure spending.

  • If DeepSeek’s claims of developing advanced AI with minimal investment prove true, major tech companies might reduce their chip purchases
  • The development could lead hyperscalers (Amazon, Microsoft, Google) to redirect their focus toward creating more efficient AI models
  • Meta Platforms showed positive performance, possibly due to potential cost savings from reduced AI infrastructure spending

Data center sector effects: Companies providing data center infrastructure and power solutions faced significant pressure.

  • Eaton’s stock declined approximately 15%
  • Vertiv shares fell nearly 30%
  • GE Vernova experienced a decline of almost 22%

Alternative perspective: Some market participants view DeepSeek’s developments as potentially positive for the tech sector.

  • More efficient AI development could lead to wider adoption and increased chip demand
  • Software companies with established AI products, like Salesforce, saw gains
  • The situation highlights the complex relationship between AI efficiency and market demand

Healthcare sector strength: The healthcare sector demonstrated resilience and growth amid the AI market turbulence.

  • Abbott Laboratories reached its highest trading levels since February 2022
  • Previous market uncertainty around healthcare stocks created buying opportunities
  • The sector’s recovery shows how market pessimism can create valuable investment openings

Looking ahead: Important catalysts could provide clarity on the DeepSeek situation and broader market direction.

  • Meta Platforms and Microsoft earnings calls later in the week may address DeepSeek implications
  • Several major companies across various sectors are scheduled to report earnings
  • Market participants await guidance on AI investment strategies from tech leaders

Market implications and uncertainties: The DeepSeek development represents a critical moment for AI investment dynamics and market sentiment, though many questions remain unanswered about its true impact on computational efficiency and industry spending patterns.

Our health-care stocks keep on climbing as DeepSeek fears pressure most of our AI names

Recent News

Anthropic secures $3.5 billion at $61.5 billion valuation amid AI funding surge

Safety-focused AI startup reaches billion-dollar revenue milestone as enterprise adoption of its chatbot Claude drives unprecedented growth.

AI agents could make the internet go dark, top analysts warn

AI assistants acting as digital middlemen could drastically reduce direct human visits to websites and apps, upending current online business models.

OpenAI launches GPT-4.5 with groundbreaking new capabilities, comprehension level-up

Building on recent advancements in unsupervised learning, the model cuts AI hallucination rates nearly in half while improving pattern recognition and creative insight generation.